Literature DB >> 12745747

Intercurrent autoimmune conditions in classic and non-ulcer interstitial cystitis.

Ralph Peeker1, Liliana Atanasiu, Yr Logadottir.   

Abstract

OBJECTIVE: Interstitial cystitis (IC) is known to be one of the most bothersome conditions encountered in urological practice. It is frequently divided into two subtypes: classic and non-ulcer. Several authors have reported on autoantibodies in patients with IC and clinical and histopathological findings show similarities with those in some autoimmune disorders. Furthermore, IC has been shown to be associated with autoimmune diseases such as systemic lupus erythematosus, Sjögren's syndrome and autoimmune diseases of the thyroid gland. Our aim was to study the occurrence of associated autoimmune conditions in patients with IC diagnosed according to the National Institutes of Health/National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases criteria.
MATERIAL AND METHODS: Our sample of IC patients consisted of 129 with classic IC and 93 with non-ulcer IC. Clinical records, including micturition charts, were surveyed, and a more in-depth interview was obtained by means of a telephone call. Autoimmune disorders, diagnosed by Swedish clinicians according to acknowledged diagnostic criteria, were registered.
RESULTS: Allergy was the most common IC-associated condition, 41% of all patients with classic IC and 47% of all patients with non-ulcer IC having some type or degree of hypersensitivity/allergy. Rheumatoid arthritis occurred in 13% of patients with classic IC and in 4% with non-ulcer IC. Inflammatory bowel disease was not diagnosed in any of the patients with non-ulcer IC whereas 2.3% of the patients with classic IC had either ulcerative colitis or Crohn's disease, approximately 33 times the prevalence seen in the general population.
CONCLUSION: It appears that systemic and autoimmune disorders are more prevalent in the IC population than in the general population.

Entities:  

Mesh:

Year:  2003        PMID: 12745747     DOI: 10.1080/00365590310008721

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  15 in total

Review 1.  Models of inflammation of the lower urinary tract.

Authors:  Dale E Bjorling; Zun-Yi Wang; Wade Bushman
Journal:  Neurourol Urodyn       Date:  2011-06       Impact factor: 2.696

2.  Urinary bladder epithelium antigen induces CD8+ T cell tolerance, activation, and autoimmune response.

Authors:  Wujiang Liu; David P Evanoff; Xiaohong Chen; Yi Luo
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

3.  Cystitis-induced bladder pain is Toll-like receptor 4 dependent in a transgenic autoimmune cystitis murine model: a MAPP Research Network animal study.

Authors:  Xiangrong Cui; Xuan Jing; Susan K Lutgendorf; Catherine S Bradley; Andrew Schrepf; Bradley A Erickson; Vincent A Magnotta; Timothy J Ness; Karl J Kreder; Michael A O'Donnell; Yi Luo
Journal:  Am J Physiol Renal Physiol       Date:  2019-05-15

4.  Role of inflammation in bladder function and interstitial cystitis.

Authors:  Sonal Grover; Abhishek Srivastava; Richard Lee; Ashutosh K Tewari; Alexis E Te
Journal:  Ther Adv Urol       Date:  2011-02

5.  Establishment of a Novel Autoimmune Experimental Model of Bladder Pain Syndrome/Interstitial Cystitis in C57BL/6 Mice.

Authors:  Xing-Wei Jin; Bo-Ke Liu; Xiang Zhang; Zhong-Hua Zhao; Yuan Shao
Journal:  Inflammation       Date:  2017-06       Impact factor: 4.092

Review 6.  Interstitial cystitis/bladder pain syndrome: The evolving landscape, animal models and future perspectives.

Authors:  Yoshiyuki Akiyama; Yi Luo; Philip M Hanno; Daichi Maeda; Yukio Homma
Journal:  Int J Urol       Date:  2020-04-04       Impact factor: 3.369

Review 7.  [Interstitial cystitis. An important differential diagnosis].

Authors:  A van Ophoven; F Oberpenning
Journal:  Urologe A       Date:  2006-04       Impact factor: 0.639

8.  Intravesical dimethyl sulfoxide inhibits acute and chronic bladder inflammation in transgenic experimental autoimmune cystitis models.

Authors:  Ronald Kim; Wujiang Liu; Xiaohong Chen; Karl J Kreder; Yi Luo
Journal:  J Biomed Biotechnol       Date:  2010-11-11

9.  RDP58 inhibits T cell-mediated bladder inflammation in an autoimmune cystitis model.

Authors:  Wujiang Liu; Barry R Deyoung; Xiaohong Chen; David P Evanoff; Yi Luo
Journal:  J Autoimmun       Date:  2007-12-26       Impact factor: 7.094

Review 10.  Treatment approaches for painful bladder syndrome/interstitial cystitis.

Authors:  Theoharis C Theoharides
Journal:  Drugs       Date:  2007       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.